Search Results

Pediatric Bipolar Disorder: Underdiagnosed or Fiction?

Author: Sahling, Daniel L.

Source: Ethical Human Psychology and Psychiatry, Volume 11, Number 3, 2009 , pp. 215-228(14)

Publisher: Springer Publishing Company

When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study

Authors: Farah, Martha; Haimm, Caroline; Sankoorikal, Geena; Chatterjee, Anjan

Source: Psychopharmacology, Volume 202, Numbers 1-3, January 2009 , pp. 541-547(7)

Publisher: Springer

Hematologic changes associated with Adderall toxicity in a dog

Authors: Wilcox, Angela; Russell, Karen E.

Source: Veterinary Clinical Pathology, Volume 37, Number 2, June 2008 , pp. 184-189(6)

Publisher: Blackwell Publishing

Adderall: Cardiomyopathy: case report

Source: Reactions, Volume 1, Number 1204, 2008-05-31 , pp. 5-5(1)

Publisher: Adis International

Pharmacokinetic Modeling and Simulation of Gastrointestinal Transit Effects on Plasma Concentrations of Drugs from Mixed Immediate-Release and Enteric-Coated Pellet Formulations

Authors: Watanalumlerd, Prapoch; Christensen, J. Mark; Ayres, James W.

Source: Pharmaceutical Development and Technology, Volume 12, Number 2, March 2007 , pp. 193-202(10)

Publisher: Informa Healthcare

Our Drugs Are Better Than Yours: Schools and Their Hypocrisy Regarding Drug Use

Author: Finley, Laura

Source: Contemporary Justice Review, Volume 10, Number 4, December 2007 , pp. 365-381(17)

Publisher: Routledge, part of the Taylor & Francis Group

Adderall Abuse in Texas, 1998-2004

Author: Forrester, Mathias

Source: Journal of Toxicology and Environmental Health Part A, Volume 70, Number 7, January 2007 , pp. 658-664(7)

Publisher: Taylor and Francis Ltd

Adderall/methylphenidate: Psychodermatological disorders: 4 case reports

Source: Reactions, Volume 1, Number 1177, 2007-11-10 , pp. 5-5(1)

Publisher: Adis International

Adderall interaction: Interaction with concomitant varenicline leading to reduced efficacy of varenicline: case report

Source: Reactions, Volume 1, Number 1174, 2007-10-20 , pp. 4-4(1)

Publisher: Adis International

Preventing smoking in children and adolescents with ADHD

Source: Inpharma, Volume 1, Number 1603, 2007-09-01 , pp. 13-13(1)

Publisher: Adis International

Treatment of attention deficit hyperactivity disorder in adults

Authors: Greenfield, Brain; Hechman, Lily

Source: Expert Review of Neurotherapeutics, Volume 5, Number 1, January 2007 , pp. 107-121(15)

Publisher: Expert Reviews

Salivary Biomarker Levels and Diurnal Variation: Associations With Medications Prescribed to Control Children's Problem Behavior

Authors: Hibel, Leah C.; Granger, Douglas A.; Cicchetti, Dante; Rogosch, Fred

Source: Child Development, Volume 78, Number 3, May/June 2007 , pp. 927-937(11)

Publisher: Blackwell Publishing

Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release

Authors: Ermer, James C.; Shojaei, Amir; Pennick, Michael; Anderson, Colleen S.; Silverberg, Arthur; Youcha, Sharon H.

Source: Current Medical Research and Opinion, Volume 23, Number 5, May 2007 , pp. 1067-1075(9)

Publisher: Informa Healthcare

Adderall^® produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers

Authors: Joyce, B.; Glaser, Paul; Gerhardt, Greg

Source: Psychopharmacology, Volume 191, Number 3, April 2007 , pp. 669-677(9)

Publisher: Springer

Patients receiving pharmacotherapies for attention-deficit hyperactivity disorder (ADHD) must be informed of potential cardiovascular and psychiatric adverse events

Source: Reactions, Volume 1, Number 1141, 2007-03-03 , pp. 2-2(1)

Publisher: Adis International

Patients receiving pharmacotherapies for attention-deficit hyperactivity disorder (ADHD) must be informed of potential cardiovascular and psychiatric adverse events

Source: Inpharma, Volume 1, Number 1577, 2007-03-03 , pp. 22-22(1)

Publisher: Adis International

On the Implications and Consequences of a Neurobiochemical Etiology of Attention Deficit Hyperactive Disorder (ADHD)

Author: Seitler, Burton Norman

Source: Ethical Human Psychology and Psychiatry, Volume 8, Number 3, 2006 , pp. 229-240(12)

Publisher: Springer Publishing Company

SPD 465 [Adderall] is an effective treatment for attention-deficit hyperactivity disorder (ADHD) in adults

Source: Inpharma, Volume 1, Number 1563, 2006-11-11 , pp. 9-9(1)

Publisher: Adis International

Extended-release (OROS) methylphenidate is more effective than SLI 381 [Adderall XR] for improving driving performance in adolescents with ADHD

Source: Inpharma, Volume 1, Number 1560, 2006-10-21 , pp. 12-12(1)

Publisher: Adis International

Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder

Author: Grcevich, Stephen

Source: Future Neurology, Volume 1, Number 5, September 2006 , pp. 525-534(10)

Publisher: Future Medicine